Article

<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine

2023-06-16

Abstract excerpt

Lung cancer is the leading cause of global cancer-related mortality resulting in ~1.8 million deaths annually. Systemic, molecular targeted, and immune therapies have provided significant improvements of survival outcomes for patients. However, drug resistance usually arises and there is an urgent need for novel therapy screening and personalized medicine. 3D patient-derived organoid (PDO) models have emerged as a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 21af8286-438c-546f-92eb-9b42a02b9fcc
DOI: 10.20944/preprints202306.1176.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

<em>Ex Vivo</em> Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized MedicineDOI 10.20944/preprints202306.1176.v1Read

Human Lung Adenocarcinoma-Derived Organoid Models for Drug ScreeningSemantic proximity Read

Patient-derived tumor organoids from resected non-small cell lung cancers for high-throughput response testing with approved and repurposed drugsSemantic proximity Read

Patient-derived organoids from malignant pleural effusion to explore for alternative therapies in thoracic tumorsSemantic proximity Read

An optimized method to culture human primary lung tumor cell spheroidsSemantic proximity Read

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screeningSemantic proximity Read

Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patientsSemantic proximity Read

Lung tumoroids as a testing platform for precision CAR T-cell therapySemantic proximity Read

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a weekSemantic proximity Read

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma.Semantic proximity Read

A novel artificial lung organoid for simulating a patient derived adenocarcinoma of lung for personalized oncologySemantic proximity Read

Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.Semantic proximity Read

Patient-derived organoids in translational oncology and drug screeningSemantic proximity Read